These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
533 related articles for article (PubMed ID: 27470562)
21. Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron. Wang YQ; Wang MY; Fu XR; Peng-Yu ; Gao GF; Fan YM; Duan XL; Zhao BL; Chang YZ; Shi ZH Free Radic Res; 2015; 49(9):1069-80. PubMed ID: 25968939 [TBL] [Abstract][Full Text] [Related]
22. Astragaloside-IV regulates endoplasmic reticulum stress-mediated neuronal apoptosis in a murine model of Parkinson's disease via the lincRNA-p21/CHOP pathway. Ge B; Li SL; Li FR Exp Mol Pathol; 2020 Aug; 115():104478. PubMed ID: 32511947 [TBL] [Abstract][Full Text] [Related]
23. Decrease in Han S; Seo MH; Lim S; Yeo S Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422 [TBL] [Abstract][Full Text] [Related]
24. β-asarone increases MEF2D and TH levels and reduces α-synuclein level in 6-OHDA-induced rats via regulating the HSP70/MAPK/MEF2D/Beclin-1 pathway: Chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression. Huang L; Deng M; He Y; Lu S; Liu S; Fang Y Behav Brain Res; 2016 Oct; 313():370-379. PubMed ID: 27444243 [TBL] [Abstract][Full Text] [Related]
25. Neurochemical effects of the R form of α-lipoic acid and its neuroprotective mechanism in cellular models of Parkinson's disease. Zhao H; Zhao X; Liu L; Zhang H; Xuan M; Guo Z; Wang H; Liu C Int J Biochem Cell Biol; 2017 Jun; 87():86-94. PubMed ID: 28390981 [TBL] [Abstract][Full Text] [Related]
26. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway. Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo. Doo AR; Kim SN; Park JY; Cho KH; Hong J; Eun-Kyung K; Moon SK; Jung WS; Lee H; Jung JH; Park HJ J Ethnopharmacol; 2010 Sep; 131(2):433-42. PubMed ID: 20633628 [TBL] [Abstract][Full Text] [Related]
28. Administration of resveratrol improved Parkinson's disease-like phenotype by suppressing apoptosis of neurons via modulating the MALAT1/miR-129/SNCA signaling pathway. Xia D; Sui R; Zhang Z J Cell Biochem; 2019 Apr; 120(4):4942-4951. PubMed ID: 30260025 [TBL] [Abstract][Full Text] [Related]
29. [ Wang F; Zhang Z; Sun Y; Yang L; Guo T; Pan Y; Ding S; Jiang L; Liu H Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):876-884. PubMed ID: 38862445 [TBL] [Abstract][Full Text] [Related]
30. Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice. Mani S; Sekar S; Barathidasan R; Manivasagam T; Thenmozhi AJ; Sevanan M; Chidambaram SB; Essa MM; Guillemin GJ; Sakharkar MK Neurotox Res; 2018 Apr; 33(3):656-670. PubMed ID: 29427283 [TBL] [Abstract][Full Text] [Related]
31. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice. Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572 [TBL] [Abstract][Full Text] [Related]
32. Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model. Tasaki Y; Yamamoto J; Omura T; Sakaguchi T; Kimura N; Ohtaki K; Ono T; Suno M; Asari M; Ohkubo T; Noda T; Awaya T; Shimizu K; Matsubara K Neurosci Lett; 2012 Jul; 521(1):15-9. PubMed ID: 22617635 [TBL] [Abstract][Full Text] [Related]
33. The long noncoding RNA HOTAIR promotes Parkinson's disease by upregulating LRRK2 expression. Wang S; Zhang X; Guo Y; Rong H; Liu T Oncotarget; 2017 Apr; 8(15):24449-24456. PubMed ID: 28445933 [TBL] [Abstract][Full Text] [Related]
34. Baicalin Represses C/EBP Lei K; Shen Y; He Y; Zhang L; Zhang J; Tong W; Xu Y; Jin L Oxid Med Cell Longev; 2020; 2020():8951907. PubMed ID: 32566108 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein. Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343 [TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817 [TBL] [Abstract][Full Text] [Related]
37. Apelin-36 mitigates MPTP/MPP Zhu J; Dou S; Wang C; Jiang Y; Wang C; Cheng B Brain Res; 2019 Oct; 1721():146334. PubMed ID: 31306618 [TBL] [Abstract][Full Text] [Related]
38. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein. Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361 [TBL] [Abstract][Full Text] [Related]
39. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model. Seo MH; Yeo S Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636 [TBL] [Abstract][Full Text] [Related]
40. LncRNA-UCA1 promotes PD development by upregulating SNCA. Lu M; Sun WL; Shen J; Wei M; Chen B; Qi YJ; Xu CS Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7908-7915. PubMed ID: 30536337 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]